Cost Effectiveness of Multigene Panel Sequencing for Patients With Advanced Non-Small-Cell Lung Cancer.
Sign Up to like & getrecommendations! Published in 2019 at "JCO clinical cancer informatics"
DOI: 10.1200/cci.19.00002
Abstract: PURPOSE Compared with single-marker genetic testing (SMGT), multigene panel sequencing (MGPS) has the potential to identify more patients with cancer who could benefit from targeted therapies, but the effects on outcome and total cost of… read more here.
Keywords: mgps; cancer; cost effectiveness; cost ... See more keywords